News Seattle, Takeda aim for first line Adcetris use Seattle CEO hopes Adcetris will be standard of care.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
News Regulators finally back Merck KGaA oral MS drug A long-awaited oral multiple sclerosis drug from Merck KGaA was among a raft of medicines given the green light by Europe's regulator on Friday.
News Genentech's subcutaneous rituximab approved in US Subcutaneous version gives more convenient injection lasting minutes, rather than several hours.
News CRUK launches next phase of cancer 'Grand Challenge' Charity launches second set of research challenges.
Views & Analysis Immuno-oncology drugs: key to the Cancer Moonshot? Assessing the global challenges inhibiting immuno-oncology market access.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
